Financial Statements — NYAX
Balance Sheet
(in millions USD)| Metric | Q2
2024 | Q2
2023 |
|---|
| Cash & Equivalents | 61.91 | 31.05 |
| Inventory | 20.31 | 22.92 |
| Total Current Assets | 290.85 | 177.86 |
| Total Non-current Assets | 143.84 | 83.96 |
| Total Assets | 434.69 | 261.83 |
| Total Current Liabilities | 232.17 | 151.23 |
| Total Non-current Liabilities | 43.83 | 10.65 |
| Total Liabilities | 276.00 | 161.87 |
| Retained Earnings | (70.24) | (62.58) |
| Total Stockholder Equity | 158.69 | 99.96 |
Income Statement
(in millions USD) (except per-share rows)| Metric | Q2
2024 | Q2
2023 |
|---|
| Total Revenue | 78.09 | 56.16 |
| Cost of Revenue* | 43.50 | 35.30 |
| Gross Profit | 34.59 | 20.86 |
| Research & Development | 6.42 | 4.97 |
| Selling, General & Admin | 23.82 | 17.54 |
| Total Operating Expenses* | 33.68 | 24.56 |
| Operating Income | 0.91 | (3.71) |
| Pretax Income | (2.69) | (3.75) |
| Tax Provision | 0.32 | 0.23 |
| Net Income | (3.01) | (3.97) |
| Basic EPS | (0.08) | (0.12) |
| Diluted EPS | (0.08) | (0.12) |
* Derived from reported values
Cash Flow Statement
(in millions USD)| Metric | Q2
2024 | Q2
2023 |
|---|
| Operating Cash Flow | 9.19 | (1.66) |
| Investing Cash Flow | (20.52) | (5.97) |
| Financing Cash Flow | 4.27 | 4.91 |
